Researchers at Northwestern University have successfully restored walking ability in paralyzed mice using an innovative gel treatment. Published in Science on November 11, 2021, this breakthrough shows no side effects and holds immense promise for human spinal cord injury patients.
For individuals with paralysis, hope for meaningful recovery has been scarce. Yet, a study from Northwestern University in Chicago offers new optimism. Scientists severed the spinal cords of mice to induce paralysis, then injected an experimental gel directly into the injury site. Remarkably, within four weeks, the mice regained their ability to walk.
Lead researcher Samuel Stupp, a pioneer in regenerative medicine, notes that no existing treatment fully regenerates the spinal cord. The central nervous system, encompassing the brain and spinal cord, lacks natural repair mechanisms after trauma or degeneration. Previous approaches like gene therapies and stem cells have fallen short of expectations.
This gel's unique formulation keeps therapeutic molecules dynamic and mobile, ensuring superior tissue penetration and efficacy. It fully biodegrades within weeks, leaving no trace or side effects.
The study highlights multiple regenerative effects: axon tips regrow, scar tissue recedes (removing barriers to healing), myelin sheaths reform to enhance signal transmission, functional blood vessels form to deliver nutrients, and more motor neurons survive. These outcomes, backed by rigorous peer-reviewed research, signal a potential revolution in treating paralysis.
The Northwestern team continues refining this therapy, optimistic about translating these results to humans and transforming lives for those with spinal cord injuries.
